| 000 | 01733 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516181052.0 | ||
| 264 | 0 | _c20141021 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1875-8908 | ||
| 024 | 7 |
_a10.3233/JAD-130845 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDarreh-Shori, Taher | |
| 245 | 0 | 0 |
_aPharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors. _h[electronic resource] |
| 260 |
_bJournal of Alzheimer's disease : JAD _c2014 |
||
| 300 |
_a423-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcholinesterase _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aAlzheimer Disease _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xcerebrospinal fluid |
| 650 | 0 | 4 | _aBenzothiazoles |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aButyrylcholinesterase _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDonepezil |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFluorescence |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndans _xadministration & dosage |
| 650 | 0 | 4 |
_aPhysostigmine _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
| 650 | 0 | 4 | _aThiazoles |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aHosseini, Sharokh Makvand | |
| 700 | 1 | _aNordberg, Agneta | |
| 773 | 0 |
_tJournal of Alzheimer's disease : JAD _gvol. 39 _gno. 2 _gp. 423-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3233/JAD-130845 _zAvailable from publisher's website |
| 999 |
_c23253353 _d23253353 |
||